References
- Longley D. B., Johnston P. G.. Molecular mechanisms of drug resistance. J. Pathol.. 2000; 205:275–292.
- Redmond K. M., Wilson T. R., Johnston P. G., Longley D. B.. Resistance mechanisms to cancer chemotherapy. Front. Biosci.. 2008; 13:5138–5154.
- Revesz L.. Effect of tumour cells killed by x-rays upon the growth of admixed viable cells. Nature. 1956; 178:1391–1392.
- Chera S., Ghila L., Dobretz K., . Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration. Dev. Cell. 2009; 17:279–289.
- Huang Q., Li F., Liu X., . Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med.. 2011; 17:860–866.
- Sun Y., Campisi J., Higano C., . Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat. Med.. 2012; 18:1359–1368.
- Fridman W. H., Teillaud J. L., Sautes-Fridman C., . The ultimate goal of curative anti-cancer therapies: inducing an adaptive anti-tumor immune response. Front. Immunol.. 2011; 2:66.
- Dunn G. P., Old L. J., Schreiber R. D.. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004; 21:137–148.
- von Boehmer H., Waldmann H.. Immunological tolerance. Front. Immunol.. 2010; 1:102.
- Gaipl U. S., Munoz L. E., Rodel F., . Modulation of the immune system by dying cells and the phosphatidylserine-ligand annexin A5. Autoimmunity. 2007; 40:254–259.
- Pandiyan P., Zheng L., Lenardo M. J.. The molecular mechanisms of regulatory T cell immunosuppression. Front. Immunol.. 2011; 2:60.
- Munoz L. E., Frey B., Pausch F., . The role of annexin A5 in the modulation of the immune response against dying and dead cells. Curr. Med. Chem.. 2007; 14:271–277.
- Frey B., Schildkopf P., Rodel F., . AnnexinA5 renders dead tumor cells immunogenic–implications for multimodal cancer therapies. J. Immunotoxicol.. 2009; 6:209–216.
- Gregory C. D., Pound J. D.. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J. Pathol.. 2011; 223:177–194.
- Peter C., Waibel M., Keppeler H., . Release of lysophospholipid ‘find-me’ signals during apoptosis requires the ATP-binding cassette transporter A1. Autoimmunity. 2012; 45:568–573.
- Lauber K., Bohn E., Krober S. M., . Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 2003; 113:717–730.
- Fadok V. A., Voelker D. R., Campbell P. A., . Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol.. 1992; 148:2207–2216.
- Chaurio R. A., Janko C., Munoz L. E., . Phospholipids: key players in apoptosis and immune regulation. Molecules. 2009; 14:4892–4914.
- Voll R. E., Herrmann M., Roth E. A., . Immunosuppressive effects of apoptotic cells. Nature. 1997; 390:350–351.
- Morelli A. E., Larregina A. T.. Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis. 2010; 15:1083–1097.
- Mollereau B., Perez-Garijo A., Bergmann A., . Compensatory proliferation and apoptosis-induced proliferation: a need for clarification. Cell Death Differ.. 2012; 20:181.
- Lauber K., Munoz L. E., Berens C., . Apoptosis induction and tumor cell repopulation: The yin and yang of radiotherapy. Radiat. Oncol.. 2011; 6:176.